HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$33.03
Day range
$32.35 - $33.38
Year range
$26.74 - $46.00
Market cap
2.52B USD
Avg Volume
710.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.00M | 42.68% |
Net income | -65.68M | -46.81% |
Net profit margin | — | — |
Earnings per share | -0.84 | -31.25% |
EBITDA | -76.84M | -45.42% |
Effective tax rate | 5.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 626.90M | -1.75% |
Total assets | 798.14M | -17.27% |
Total liabilities | 43.24M | 17.24% |
Total equity | 754.90M | — |
Shares outstanding | 76.54M | — |
Price to book | 3.34 | — |
Return on assets | -23.71% | — |
Return on capital | -24.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -65.68M | -46.81% |
Cash from operations | -54.38M | -53.63% |
Cash from investing | 98.50M | 141.08% |
Cash from financing | 12.13M | -96.26% |
Net change in cash | 55.09M | 12.27% |
Free cash flow | -31.80M | -26.40% |
About
Founded
1996
Headquarters
Website
Employees
322
